Home > Boards > US Listed > Medical - Drugs > MyMD Pharmaceuticals Inc (MYMD)

The Science Update call was extremely well done.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
leifsmith Member Profile
 
Followed By 58
Posts 11,963
Boards Moderated 0
Alias Born 02/09/09
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/24/2021 12:56:50 PM
MyMD Pharma expands IP portfolio with another patent win for lead asset Seeking Alpha - 11/23/2021 10:03:28 AM
MyMD Pharmaceuticals Announces Issuance of U.S. Patent Covering Lead Drug Candidate MYMD-1 in a Method of Extending Lifespan Business Wire - 11/23/2021 9:25:00 AM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 11/22/2021 5:28:59 PM
MyMD Pharmaceuticals Investment Company Oravax Medical and Genomma Lab Announce Joint Venture to Develop and Commercialize Oral COVID-19 Vaccine in Mexico and Drive Business Development in Latin America Business Wire - 11/18/2021 9:15:00 AM
MyMD Pharma secures FDA clearance to begin Phase 2 trial of MYMD-1 to delay aging Seeking Alpha - 11/16/2021 9:55:07 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/16/2021 9:26:43 AM
MyMD Pharmaceuticals Receives FDA IND Clearance to Begin Phase 2 Trial of MYMD-1 for Extending Healthy Lifespan Business Wire - 11/16/2021 9:25:00 AM
Amended Quarterly Report (10-q/a) Edgar (US Regulatory) - 11/15/2021 4:54:32 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/12/2021 5:01:41 PM
MyMD Pharmaceuticals President Chris Chapman, M.D. Named Medical Honoree of the Year by the Arthritis Foundation Business Wire - 10/26/2021 10:30:00 AM
MyMD Pharmaceuticals to Discuss its Novel Therapies for Aging and Related Diseases at the Dawson James Securities 6th Annual Small Cap Growth Conference on October 21 Business Wire - 10/19/2021 10:30:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/15/2021 5:24:19 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/15/2021 5:22:52 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/15/2021 5:22:45 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/15/2021 5:22:35 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/5/2021 10:00:56 AM
MyMD Pharmaceuticals to Detail its Two Upcoming Phase 2 Trials at the Benzinga Rising Stars: Catalytic Small Cap Growth Conference on October 7 Business Wire - 10/5/2021 10:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/22/2021 12:53:15 PM
MyMD Pharmaceuticals Announces New Data Demonstrating 8,000 Times Higher Potency of Novel Synthetic Supera-CBD over Plant-Derived CBD Business Wire - 9/22/2021 11:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/13/2021 5:31:32 PM
MyMD Pharmaceuticals Announces Fourth Quarter 2021 Initiation of Phase 2 Clinical Trial of MYMD-1 for Extending Healthy Lifespan Business Wire - 9/13/2021 10:00:00 AM
MyMD Pharmaceuticals to Present its Novel Therapeutic Platforms for Extending Healthy Lifespan at the H.C. Wainwright 23rd Annual Global Investment Conference September 13-15 Business Wire - 9/9/2021 10:15:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/3/2021 4:38:53 PM
MyMD Pharmaceuticals Announces Issuance of U.S. Patent for Use of Lead Candidate MYMD-1 for Treating Fibrosis and Asthma Business Wire - 8/24/2021 10:17:00 AM
leifsmith   Monday, 05/17/21 04:47:36 PM
Re: None
Post # of 206 
The Science Update call was extremely well done. It was accompanied by minimal but informative video. If they make the recording available anyone interested in MYMD should watch it.

Historical note: Watching MYMD is like watching a grown up Star Scientific. Very good to see.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences